A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT07754786 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07754786
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-20
- Primary completion
- 2028-07-01
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.